Cluj Napoca Romania

1 Introduction Acute promyelocytic leukaemia (APL) is a unique biological and clinical variant of acute myeloid leukaemia, accounting for up to 10%–15% of the newly diagnosed acute myeloid leukaemias in adults [1-3].